James Investment Research Inc Vanda Pharmaceuticals Inc. Transaction History

James Investment Research Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$6.87 - $10.96 $3,881 - $6,192	-565 Reduced 1.28%	43,517 $322,000
Q1 2021 Apr 22, 2021	BUY	$13.42 - $20.28 $327,072 - $494,264	24,372 Added 123.65%	44,082 $662,000
Q4 2020 Jan 27, 2021	BUY	$9.77 - $13.81 $244 - $345	25 Added 0.13%	19,710 $259,000
Q2 2020 Jul 24, 2020	BUY	$9.66 - $12.02 $14,538 - $18,090	1,505 Added 8.28%	19,685 $225,000
Q1 2020 Apr 22, 2020	BUY	$7.5 - $16.8 $136,350 - $305,424	18,180 New	18,180 $188,000
Q1 2019 Apr 26, 2019	SELL	$17.59 - $31.05 $728,226 - $1.29 Million	-41,400 Closed	0 $0
Q4 2018 Jan 22, 2019	BUY	$18.97 - $31.47 $785,358 - $1.3 Million	41,400 New	41,400 $1.08 Million

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $278M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

Stay updated on James Investment Research Inc with notifications on news.